Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Evogene (EVGN) Tax Provisions (2016 - 2024)

Historic Tax Provisions for Evogene (EVGN) over the last 9 years, with Q4 2024 value amounting to $7000.0.

  • Evogene's Tax Provisions rose 27500.0% to $7000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was -$2000.0, marking a year-over-year change of. This contributed to the annual value of $9000.0 for FY2024, which is 12727.27% up from last year.
  • As of Q4 2024, Evogene's Tax Provisions stood at $7000.0, which was up 27500.0% from -$4000.0 recorded in Q4 2023.
  • In the past 5 years, Evogene's Tax Provisions ranged from a high of $45000.0 in Q4 2022 and a low of -$45000.0 during Q1 2023
  • Moreover, its 5-year median value for Tax Provisions was $5500.0 (2020), whereas its average is $6812.5.
  • Its Tax Provisions has fluctuated over the past 5 years, first soared by 116666.67% in 2022, then plummeted by 235000.0% in 2023.
  • Over the past 5 years, Evogene's Tax Provisions (Quarter) stood at $25000.0 in 2020, then tumbled by 124.0% to -$6000.0 in 2021, then soared by 850.0% to $45000.0 in 2022, then tumbled by 108.89% to -$4000.0 in 2023, then skyrocketed by 275.0% to $7000.0 in 2024.
  • Its last three reported values are $7000.0 in Q4 2024, -$4000.0 for Q4 2023, and -$5000.0 during Q3 2023.